Article info
PDFPostScript
PostScript
Meta-analysis of the efficacy and safety of PD-1/PD-L1 inhibitors administered alone or in combination with anti-VEGF agents in advanced hepatocellular carcinoma
- Correspondence to Dr Pengfei Rong, Changsha, China; rongpengfei66{at}163.com
Citation
Meta-analysis of the efficacy and safety of PD-1/PD-L1 inhibitors administered alone or in combination with anti-VEGF agents in advanced hepatocellular carcinoma
Publication history
- Received October 18, 2019
- Revised December 10, 2019
- Accepted December 10, 2019
- First published December 18, 2019.
Online issue publication
December 06, 2020
Article Versions
- Previous version (7 September 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.